Chemical Safety
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[γ]-2-benzopyran (HHCB); Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Data Availability and Request for Comment. EPA TSCA notice. Summary: “The Environmental Protection Agency (EPA or Agency) is announcing the availability of data and supporting materials related to the draft risk evaluation under the Toxic Substances Control Act (TSCA) for 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[γ]-2-benzopyran (HHCB) (CASRN 1222-05-5). These materials are intended to inform the public and interested parties about the information considered by the Agency in the draft risk evaluation. During the public comment period for the draft risk evaluation of HHCB (April 14, 2026, to June 15, 2026), EPA became aware of an inadvertent administrative issue in its Health and Environmental Research Online (HERO) system that made 24 industry-submitted studies considered in Draft Risk Evaluation for 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[γ]-2-benzopyran (HHCB) unavailable to the public. On October 14, 2026, this issue was resolved and the studies were made available to the public in HERO.”
ADS Equipped Vehicles
Federal Motor Vehicle Safety Standards; Modernization of FMVSS No. 108 To Accommodate ADS-Equipped Vehicles. NHTSA extension of comment period. Summary: “In response to requests from the Alliance for Automotive Innovation (the Alliance), Society of Automotive Engineers (SAE) International, and Gatik AI Inc. (Gatik), NHTSA is announcing a 15-day extension of the public comment period for the notice of proposed rulemaking (NPRM) published on October 26, 2026 proposing to amend Federal Motor Vehicle Safety Standard (FMVSS) No. 108, “Lamps, reflective devices, and associated equipment.” The proposed modifications would distinguish how regulations apply to vehicles with and without manually operated driving controls. The comment period for the notice was originally scheduled to end on November 25, 2026. It will now end on December 10, 2026.”
Pipeline Safety
Pipeline Safety: Meetings of the Liquid and Gas Pipeline Advisory Committees. PHMSA meeting notice. Summary: “This notice announces public meetings of the Technical Pipeline Safety Standards Committee, also known as the Gas Pipeline Advisory Committee (GPAC), and the Technical Hazardous Liquid Pipeline Safety Standards Committee, also known as the Liquid Pipeline Advisory Committee (LPAC). The meetings will be held to discuss the notice of proposed rulemaking (NPRM), titled “Repair Criteria for Hazardous Liquid and Gas Transmission Pipelines.””
UAS
Petition for Exemption; Summary of Petition Received; Blue Vigil, LLC. FAA public notice. Summary: “This notice contains a summary of a petition seeking relief from specified requirements of Federal Aviation Regulations. The purpose of this notice is to improve the public's awareness of, and participation in, the FAA's exemption process. Neither publication of this notice nor the inclusion nor omission of information in the summary is intended to affect the legal status of the petition or its final disposition.”
West Nile Virus
Target Product Profile for a Human West Nile Virus Vaccine: Request for Information. CDC request for information. Summary: “The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for a Human West Nile Virus Vaccine. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. The objective of the target product profile is to describe key minimal and optimal attributes for a West Nile virus vaccine for humans. This input is a valuable component in developing a useful target product profile.”
Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease: Request for Information. CDC request for information. Summary: “The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease for Use in Hospitals and Clinical Laboratories. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. HHS/CDC is publishing this target product profile to improve the likelihood of developing a commercially available diagnostic assay that can be used to rapidly diagnose West Nile virus infection. Public input is a valuable component in developing a useful target product profile.”
Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention: Request for Information. CDC request for comment. Summary: “The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. The objective of the target product profile is to describe key minimal and optimal attributes for a West Nile virus monoclonal antibody product that can be provided to patients at higher risk for severe West Nile virus disease as pre- or post-exposure prophylaxis. This input is a valuable component in developing a useful target product profile.”
No comments:
Post a Comment